CA2178485A1 - Method of verifying capture of the heart by a pacemaker - Google Patents
Method of verifying capture of the heart by a pacemakerInfo
- Publication number
- CA2178485A1 CA2178485A1 CA002178485A CA2178485A CA2178485A1 CA 2178485 A1 CA2178485 A1 CA 2178485A1 CA 002178485 A CA002178485 A CA 002178485A CA 2178485 A CA2178485 A CA 2178485A CA 2178485 A1 CA2178485 A1 CA 2178485A1
- Authority
- CA
- Canada
- Prior art keywords
- signal
- capture
- amplitude
- reference value
- cardiac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
- A61N1/371—Capture, i.e. successful stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/318—Heart-related electrical modalities, e.g. electrocardiography [ECG]
- A61B5/346—Analysis of electrocardiograms
- A61B5/349—Detecting specific parameters of the electrocardiograph cycle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7239—Details of waveform analysis using differentiation including higher order derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36507—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by gradient or slope of the heart potential
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Medical Informatics (AREA)
- Signal Processing (AREA)
- Surgery (AREA)
- Pathology (AREA)
- Physiology (AREA)
- Artificial Intelligence (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Electrotherapy Devices (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
A method of verifying cardiac capture. A cardiac signal evoked in response to a cardiac stimulation pulse is sensed via an electrode. The sensed signal is lowpass filtered to remove noise and to pass frequencies characteristic of the evoked cardiac signal. The filtered signal is processed to tender a waveform signal representing the second derivative of said filtered signal and the second derivative signal is further analyzed to detect a minimum and a maximum amplitude excursion during a selected window of time beginning at a selected time delay following delivery of the cardiac stimulation pulse. The amplitude difference between the minimum and the maximum is measured and compared to a first reference value. The amplitude of the second derivative is measured during a second selected window of time beginning at a selected time delay following delivery of cardiac stimulation pulse, and compared to a second reference value. A capture detect signal is generated if the amplitute difference exceeds the first reference value, but the amplitude does not exceed the second reference value.
Description
W095/15785 ~ 1 78485 PCT/US91/1~12-1 METHOD OF VERIFYING CAPTURE OF THE HEART BY A PACEMAKER
Technical Field The present invention relates generally to cardiac pacing using an ~ pldllldbl~ cardiac stimulator, and more particularly to verification of capture of the heart following:,, ' ' 1 of an electrical stimulating pulse by the cardiac stimulator.
Ba~ y,ull"d l~rur~laLil~n A cardiac stimulator, or pacemaker, "captures" the heart by delivering an electrical pulse to the myocardium of a selected chamber during an interval in the cardiac cycle in which the cardiac tissue is excitable. The electrical pulse causes depolarization of cardiac cells and a consequent cor"ld~iun of the chamber, provided that the energy of the pacing pulse as delivered to the myocardium exceeds a threshold value.
It is desirable to adjust the pacemaker so that the energy delivered by the electrical pulse to the myocardium is at the lowest level that will reliably capture the hearL. Such a level assures therapeutic efficacy while Illd~ ;ll9 the life of the pac~",dk~l battery. E3ecause the threshold for capture varies from one illl,uldllldLiol1 to another, and can change over time, it is also desirable that the pulse energy delivered by the pact:",akt:, to the myocardium be ~jllct~hl~ during and subsequent to illlluldllLdLio~l Adjustment can be effected manually from time to time through use of an external p~uy~d~ el that communicates with the implanted pacemaker. It would be more desirable, however, to provide a pac~ ak~r that adjusts the pulse energy itself a~"u",dLica'l) and dynamically in response to changes in the capture threshold.
Changes in capture threshold can be detected by ~ullilulillg the effficacy of stimulating pulses at a given energy level. If capture does not occur at a particular stimulation energy level which previously was adequate to effect capture, then it can be surmised that the capture threshold has increased and that the stimulation energy level should be increased. On the other hand, if capture occurs col1si~"l1y at a particular stimulation level WO95/15785 . ,~ 2 1 7 8 4 8 5 PCT~Sg~ 2~ ~
Technical Field The present invention relates generally to cardiac pacing using an ~ pldllldbl~ cardiac stimulator, and more particularly to verification of capture of the heart following:,, ' ' 1 of an electrical stimulating pulse by the cardiac stimulator.
Ba~ y,ull"d l~rur~laLil~n A cardiac stimulator, or pacemaker, "captures" the heart by delivering an electrical pulse to the myocardium of a selected chamber during an interval in the cardiac cycle in which the cardiac tissue is excitable. The electrical pulse causes depolarization of cardiac cells and a consequent cor"ld~iun of the chamber, provided that the energy of the pacing pulse as delivered to the myocardium exceeds a threshold value.
It is desirable to adjust the pacemaker so that the energy delivered by the electrical pulse to the myocardium is at the lowest level that will reliably capture the hearL. Such a level assures therapeutic efficacy while Illd~ ;ll9 the life of the pac~",dk~l battery. E3ecause the threshold for capture varies from one illl,uldllldLiol1 to another, and can change over time, it is also desirable that the pulse energy delivered by the pact:",akt:, to the myocardium be ~jllct~hl~ during and subsequent to illlluldllLdLio~l Adjustment can be effected manually from time to time through use of an external p~uy~d~ el that communicates with the implanted pacemaker. It would be more desirable, however, to provide a pac~ ak~r that adjusts the pulse energy itself a~"u",dLica'l) and dynamically in response to changes in the capture threshold.
Changes in capture threshold can be detected by ~ullilulillg the effficacy of stimulating pulses at a given energy level. If capture does not occur at a particular stimulation energy level which previously was adequate to effect capture, then it can be surmised that the capture threshold has increased and that the stimulation energy level should be increased. On the other hand, if capture occurs col1si~"l1y at a particular stimulation level WO95/15785 . ,~ 2 1 7 8 4 8 5 PCT~Sg~ 2~ ~
over a relatively large number of successive stimulation cycles, it is possible that the stimulation threshold has decreased and that pacing energy is being delivered at an energy level higher than necessary. This can be verified by lowering the stimulation energy level and "lo~ u,i,lg for loss of 5 capture at the new energy level.
For automatic and dynamic adjustment of the stimulation energy level to be successful, it is necessary for the i",,ulal,~dble cardiac stimulator to be able to verify that capture has occurred. Capture verification is generally dcco",,u'i~lled by detecting an electrical potential in the heart evoked by the 10 stimulating pulse. If capture has not occurred, there will be no evoked potential to detect. It follows that each time a stimulating pulse is delivered to the heart, the heart can be monitored during an dpplU,~Iid~t: period of time thereafter to detect the presence of the evoked potential, and thereby verify capture. In practice, however, reliable detection of the evoked 15 potential is not a simple matter, especially where it is desired to sense theevoked potential with the same electrode that delivers the stimulating pulse.
This is because the evoked potential is small in amplitude relative to the residual pOIdl i~dliol1 charge on the electrode resulting from the stimulation pulse. The residual charge decays exponentially but tends to dominate the 20 evoked potential for several hundreds of ", " - 1.1~ thereafter. Several techniques for alleviating the effects of the residual charge are disclosed in the prior art.
U.S. Patent No. 4,858,610, issued August 22, 1989, to Callaghan et al., teaches the use of charge dumping following delivery of the stimulating 25 pulse to decrease lead poldli~dLiull and also the use of separate pacing and sensing electrodes to eliminate the poldli~d~iull problem on the sensing electrode. U.S. Patent No. 4,686,988, issued August 18,1987, to Sholder, teaches the use of a separate sensing electrode connected to a detector for detecting P-waves in the presence of atrial stimulation pulses, wherein the 30 P-wave detector has an input bandpass ~ dld~ Li~, selected to pass frequencies that are ~so~ t~d with P-waves. U.S. Patent No. 4,373,531 teaches the use of pre- and post-stimulation recharge pulses to neutralize WO 9S11578~ ` 2 1 7 8 4 8 5 PCT/US9.1/1 112-1 the polarization on the lead. U.S. Patent No. 4,537,201 teaches a linearization of the ~xpo~ 'ly decaying sensed signal by applying the sensed signal through an anti-loyd,iIi""ic amplifier in order to detect a remaining nonlinear component caused by the evoked potential. U.S.
Patent No. 4,674,509, issued June 23, 1987, to DeCote, Jr. teaches the gel1e~liol1 of paired pacing pulses spaced such that at most only one pulse of each pair can induce capture. The waveforms sensed through the pacing lead following the gel1eld~iol) of each of the pair of pulses are ~let;l,~,lli,.~'!y subtracted to yield a difference signal indicative of the evoked cardiac response.
It would be desirable to provide a signal p, ~ ssi"g method for use in an implantable cardiac stimulator that permits detection of cardiac evoked potentials in the presence of a residual charge from a preceding stimulation pulse in order to verify capture of the heart, and that permits use of the same electrode to sense the evoked response as was used to deliver the stimulation pulse. This and other desirable goals are met by the present invention .
Disclosure of the Invention I have invented a method for di~ llilld~illg between capture and non-capture signal mo~ IJholo~i~s that are sensed following delivery of the output pulse of a pact:l"dh~,. Observing that the non-capture potential is xpol~l ILidl in form and the evoked capture potential, while generally exponential in form, has one or more small-amplitude perturbations superimposed on the expol1t:"Ii~l waveform, the invention seeks to enhance these perturbations for ease of detection. The perturbations involve relatively abrupt slope changes, which are enhanced by processing the waveform signal by dir~ ,lLidliol1 to render the second derivative of the evoked response. Abrupt slope changes in the second derivative are used to detect morphological features indicative of capture which are otherwise often difficult to di:~,lilllilldL~. In order to eliminate detection of abrupt slope wo 95/15785 2 ~ 7 8 ~ 8 5 PCT/US9~ 12~ ~
changes caused by noise the preferred embodiment employs a lowpass filter prior to l r~1~111idliul~.
In aucurddllc~ with one aspect of the invention a method of verifying cardiac capture involves sensing via an electrode a cardiac signal evoked in response to a cardiac stimulation pulse. The sensed signal is hltered to remove noise. The hltered signal is processed to render a waveform signal ~pr~ser,1il,g the second derivative of the hltered signal. If minimum and maximum amplitude excursions of the second derivative signal occur within a selected window of time following delivery of the cardiac stimulation pulse and if the amplitude difference between the minimum and maximum exceeds a reference value then capture is determined to have occurred.
It is an object of the present invention to provide an improved method fomiibl lilllilldLillg non-capture and capture waveform morphologies as sensed by an intracardiac electrode following delivery of a cardiac stimulating pulse.
It is a further object of the present invention to provide an improved method for d;b~ lilld~illg capture waveform mu,~ oloyi~s from intrinsic col,1,duliun waveform Illor~.huluyit:s as sensed by an ill11dcdldidc electrode following delivery of a cardiac stimulating pulse.
Other objects and advantages of the present invention will be apparent from the following des,~ Jliull of a preferred tllllbodi",~"~ made with reference to the drawings.
Brief Desc.;,~,1ion of the Drawings FIG. 1 is a block diagram of the preferred embodiment of a cardiac stimulator i"co,~uordLi"g the present invention.
FIG. 2 is a block diagram of the capture sense block of FIG. 1 showing in greater particularity a capture sense analog signal plucebbi"g circuit.
FIGS. 3 4 and 5 illustrate a series of waveforms showing relevant properties of first and second derivatives of sensed waveforms.
WO95115785 ; 2 1 78485 PCI'/ITS9111~112 FIGS. 6 and 7 illustrate a series of waveforms showing the usefulness of the second derivative in discriminating between capture and non-capture sensed waveforms.
FIG. 8 illustrates a second derivative of a sensed waveform relative 5 to certain time windows and amplitude thresholds that are useful in connection with the method of the present invention.
FIG. 9 is a flow chart of the method of analyzing the second derivative of a sensed waveform to detect capture of the heart in accordance with the present invention.
Best Mode for Carrying out the Invention Referring in particular to FIG. 1, there is illustrated a block diagram of a uaut~ ah~r 10 incorporating the method of the present invention. A
luplucesaor and control circuit 20 preferably provides pacemaker control and means for pruce~illy digital signals. Mi~,lu~luc~ ol 20 has 5 inpuVoutput ports connected in a conventional manner via bi-directional bus 22 to memory 24. Memory 24 preferably includes both ROM and RAM.
The pact,n,dh~r operating routine is stored in ROM. The RAM stores various plUyldlllllldble pdldlll~ > and variables.
Microprocessor 20 preferably also has an inpuVoutput port connected 20 to a telemetry interface 26 by line 28. The pacemaker when implanted is thus able to receive pacing control pdldlllllL~ and variables from a L~d~1sl,lilL~r of an external p,oy,d"",lel and send data to a receiver of the external ~IUyldllllll~l if desired. Telemetry communication is preferably effected by ~Idl~Sl"iaSiul~ and reception, via antenna 30, of eleu~lu",ay,letic 25 radiation modulated in accordance with the data to be communicated.
Microprocessor 20 also has output ports cu~ eu~d to inputs of an atrial stimulus pulse generator 32 and a ventricular stimulus pulse generator 34 by control lines 36 and 38, respectively. Microprocessor 20 sends pulse parameter data, such as amplitude and width, as well as enable/disable and 30 pulse initiation codes to the generators 32 and 34 on the respective control lines 36 and 38.
WO 95/15785 ~ 7 8 ~ 8 5 PCT/U59.111~12 Microprocessor 20 also has input ports connected to outputs of an atrial sense amplifier 40 and a ventricular sense amplifier 42 by lines 44 and 46 respectively. The atrial and ventricular sense amplihers 40 and 42 detect occurrences of P-waves and R-waves respectively. The atrial sense amplifier 40 puts out a signal on line 44 to microprocessor 20 when a P-wave is detected. The ventricular sense amplifier 42 puts out a signal on line 46 to ~iu~upruc~ssol 20 when an R-wave is detected.
The input of the atrial sense amplifier 40 and the output of the atrial stimulus pulse generator 32 are connected to a first conductor 48 which is connected via a conventional atrial lead to a pacing/sensing electrode 50 preferably lodged within the right atrial chamber of the heart 52.
The input of the ventricular sense amplifier 42 and the output of the ventricular stimulus pulse generator 34 are connected to a second conductor 54 which is connected via a conventional ventricular lead to a pacing/sensing electrode 56 preferably lodged within the right ventricular chamber of the heart 52.
The conductors 48 and 54 conduct the stimulus pulses generated by the atrial and ventricular stimulus pulse y~ dlUI~ 32 and 34 respectively to the pacing/sensing electrodes 50 and 56. The pacing/sensing electrodes 50 and 56 and collu~pul~di,ly conductors 48 and 54 also conduct sensed cardiac electrical signals in the right atrium and right ventricle to the atrialand ventricular sense amplifiers 40 and 42 respectively.
A capture sense signal processor 58 has an input connected to conductor 54 and an output connected via line 60 to an input port of ~iu~up~ucessor 20. A signal sensed in the ventricle by electrode 56 is conducted via conductor 54 to capture sense signal processor 58 where the sensed signal is processed in a manner described further below. The processed signal from capture sense signal processor 58 is conducted via line 60 to microprocessor 20 where the signal undergoes further processing and analysis in acculdallc~ with a method described below.
The present invention contemplates detecting capture of the heart by sensing via an electrode placed in the heart an electrical potential evoked in .`, ~ 2 1 7 8 4 8 5 WO 9511578~ PCT/US9~11~1111 response to ~ ' I of a stimulating pulse A signihcant advantage of the present invention is that the same electrode that is used to deliver the stimulating pulse can also be used for detecting capture. This allows use of unipolar pacing between the lead tip and the pacer can without requiring a 5 separate ring electrode for capture detection. Alternatively, bipolar pacing between the lead tip and ring electrode can be used without requiring a third electrode. In addition, when using bipolar pacing the tip electrode can be used as the capture detection electrode. Another advantage is that non-capture can be detected within 7U ms affer delivery of the pacing pulse, 10 which is early enough to permit a backup pacing pulse to be delivered i"l",edidl~ly, if desired.
Referring to FIG. 2, the capture sense signal processor 58 of FIG. 1 is illustrated in greater detail. In the preferred embodiment, signal processor 58 includes a pre-amplifier 62 having an input to which sensed 15 electrical activity signals from the heart are applied. The input of pre-amplifier 62 is t~ lly connected via conductor 54 of an endocardial lead to the tip electrode 56 located in the right ventricle of the heart. The signal from tip electrode 56 is sensed relative to a second electrode, preferably an external conductive surface of the pa~ dh~l housing or 20 "can," in a unipolar pacing configuration. Nevertheless, it should be u~delbl~ d that the input to pre-amplifier 62 can also be ~;olllle~ d to a ring electrode Alternatively, the input to pre-amplifier 62 can be connected to the tip electrode 56 with the signal being sensed relative to a ring electrode in a bipolar pacing configuration Finally, it should be appreciated 25 that capture sense signal processor 58, while shown ~,u~ e~ d to an electrode within a ventricle, could be connected instead to an electrode within an atrium of the heart The amplified output signal of pre-amplifier 62 is applied to the input of a following lowpass filter stage 64 having a cutoff frequency of about 50 30 Hz. Lowpass filter stage 64 is employed to remove high frequency noise that is not indicative of capture but that might cause false detection of capture ~ ~f~ 21 78485 WO 95/15785 PCT/US9`1/1~112-1 The hltered output of filter stage 64 is applied to the input of a following analog to digital converter stage 66 in which the amplified and hltered analog signal is digitized for further prucessil,g by microprocessor 20 in accordance with the capture detection method described below.
FIGS~ 3, 4 and 5 illustrate some general properties of the derivatives of evoked response morphologies. More particularly, FIGS. 3(a), 4(a) and 5(a) show hypothetical evoked response morphologies FIGS. 3(b), 4(b) and 5(b) show the first derivatives of the morphologies of FIGS. 3(a), 4(a) and 5(a), respectively. FIGS. 3(c), 4(c) and 5(c) show the second derivatives of the Illoll,holoyit:s of FIGS. 3(a), 4(a) and 5(a), respectively.
An exponential, or nearly exponential, waveform 68 has a first derivative 70 and a second derivative 72 that are smooth and exponential, or nearly exponential. Exponential waveforms 74 and 76, with perturbations, have first derivatives 78 and 80, respectively, which e~dgg~ldL~ the perturbations.
The first derivative waveforms may or may not cross zero as illustrated by waveforms 78 and 80, respectively. Second derivative waveforms 82 and 84 further emphasize the perturbations and cross zero as the slope of the first derivative reaches an inflection point.
FIGS. 6 and 7 illustrate the power of the method of the present invention for di~l,lilllilldlillg an evoked response waveform indicative of capture from a non-capture waveform. FIGS. 6(a) and 7(a) show sensed waveforms representative of non-capture and capture events, respectively.
FIGS. 6(b) and 7(b) show the sensed waveforms after being lowpass filtered to remove noise. FIGS. 6(c) and 7(c) show the second derivatives of the filtered wavefomms.
A four volt, 1 millisecond wide unipolar pulse was delivered to the heart between a tip electrode of a lead and the pacemaker case. The resultant waveform was sensed between the tip and case. The task is to di:~l;lilllilld~:l the non-capture morphology 86 from the capture morphology 88. Waveforms 86 and 88 correspond to typical input waveforms to the capture sense signal processor 58 of Fig. 1. The output waveforms 90, 92 of lowpass filter 64 as shown in FIGS. 6(b) and 7(b) are difficult to WO 951157~ PCTrUS9.1~1.112 t r~
diau~ illd~ The second derivatives 94, 96 generated in a~col~dl,c~ with the method of the present invention clearly develop the perturbations in the capture Illor~ oloyy, whereas the non-capture morphology remains relatively featureless.
Referring to FIGS. 8 and 9, the method of the present invention is illustrated It should be understood that the filtered and digitized signal from capture sense signal processor 58 is analyzed by Illiulu,uruc~ssor 20 in accordance with the procedure illustrated in FIG. 9, including the prior step of I ' 'r~ Lidli~g the digitized sensed waveform to render the second 1û derivative. FIG. 8 shows a portion of the second derivative waveform having a varying amplitue A as viewed within a first window of time from about 40 msec to about 70 msec after delivery of the stimulating pulse. If both a minimum peak A1 and a maximum peak A2 are not found by the end of the 40 to 70 msec window of time, the stimulating pulse is classified as not having captured the heart, provided that the absolute value of the amplitude A has not exceeded the absolute value of an ~Ill,ui~ l!y determined threshold value Ref2, such as .00005 V/sec2, or -Ref2, such as -.00005 V/sec2, within that hrst window of time. If at least one minimum peak A1 and one maximum peak A2 (which may occur in either order) are found within the 40 to 70 msec window, but the peak-to-peak amplitude difference between A1 and A2 is less than an e",pi,iu~y determined threshold value Refl, such as .00001 V/sec2 for instance, the stimulating pulse is also classified as not having captured the heart, provided that the absolute value of the amplitude has not exceeded the absolute value of threshold value Ref2. If the peak-to-peak amplitude difference between A1 and A2 is equal to or greater than the threshold value Ref1, it is tentatively determined that capture has occurred, although it is possible that the peak-to-peak excursion has exceeded the first threshold value Ref, not due to an evoked response indicative of capture~ but due to the occurrence of an intrinsic co,lllc:,,[ioll "lallir~ d within the first window of time. Signals generated by intrinsic conllduliulls tend to be of siylliriua"lly greater magnitude than evoked l~pullses indicative of capture. The method ` 2178485 WO 95/15785 PCT/US9 1/l ll~
measures the amplitude A of the second derivative over an extended window of time, i.e., from about 40 ms to about 100 ms after deiivery of the stimulating pulse, to identify intrinsic contractions. If the absolute value of the amplitude A exceeds the absolute value of the second threshold value 5 Ref2 within the extended window of time, it is d~L~""il~ed that an intrinsic Cu"l,d-,lion has occurred. If the absolute value of the amplitude A does not exceed the absolute value of the second threshold Ref2 at any time during the extended window of time from about 40 ms to about 100 ms, and if the peak-to-peak amplitude difference has exceeded the first threshold Ref, 10 during the first window of time from about 40 ms to about 70 ms, it is d~ "i"ed that capture has occurred.
Referring in particular to FIG. 9, the method of the present invention is described in greater detail with respect to the analysis of the second derivative of the sensed waveform performed by microprocessor 20, with 15 the second derivative also being rendered by ~iu~up~uct:ssor 20. Starting at a selected delay of about 40 ms after delivery of the stimulating pulse, the method compares the absolute value of the waveform amplitude A to the absolute value of a reference value Ref2, as indicated by decision box 100. If the absolute value of the amplitude A exceeds the absolute value of 20 Ref2, it is determined that an intrinsic contraction has occurred, as indicated by box 102. If the absolute value of the amplitude A does not exceed the absolute value of Ref2, the Culllpdli~ul~ is repeated until either the absolute value of the amplitude A exceeds Ref2 or time t=70 ms is reached, as indicated by decision box 104. Alternatively, positive and negative 25 amplitude peaks A2 and A, can be compared to UUllt:::.UUI~dill9 positive and negative reference values Ref2 and -Ref2 rather than UUIII~Jdlillg the absolute value of the amplitude A to the absolute value of Ref2.
At time t=70, if the waveform has not previously been classified as an intrinsic contraction, the method determines whether an amplitude 30 maximum and minimum have been found during the interval from t=40 to t=70, as indicated by decision box 106. If both maximum and minimum peaks have not been found, it is detemmined that capture has not occurred, - : : 21 784~5 WO 95/1578~; PCT/US9~/1412~
as indicated by box 108. if both maximum and minimum amplitude peaks have been found the method determines whether the absolute value of the amplitude difference between the maximum and minimum amplitude peaks is less than a reference value Ref" as indicated by decision box 110. If the 5 amplitude difference is less than Ref" then it is d~L~ ,i"ed that capture has not occurred as indicated by box 108. If the amplitude difference is equal to or exceeds Ref" the method determines whether the absolute value of the waveform amplitude A exceeds the absolute value of Ref2 as indicated by decision box 112. If the absolue value of Ref2 is exceeded it is 10 cl~L~r"~i"ed that the waveform is the result of an intrinsic ~ d~.liUII rather than a capture as indicated by box 114. If the absolute value of the waveform amplitude A is equal to or less than the absolute value of Ref2 then the method continues to compare the absolute value of the amplitude to the absolue value of Ref2 until either the absolue value of Ref2 is exceeded or t=100 ms as indicated by decision box 116. If t=100 ms without the absolute value of Ref2 having been exceeded during the period t=70 to P100 then it is determined that a capture occurred as indicated by box 118.
In the event that c.rl 1 ~ Jn of the method described above and illustrated in FIG. 9 results in a determination of non-capture as of the end of the first window of time at t=70 as indicated by box 108 it may nevertheless be useful to continue to look for intrinsic contractions that are Illall '~ - within that portion of the extended window of time from t=70 to t=100 ms. This can be acc~",~ ed by cu"" a~i"g the absolute value of the waveform amplitude A to the absolute value of Ref2 from t=70 to t=100.
If the absolute value of Ref2 is exceeded during that time period it will be determined that a non-capture was followed by an intrinsic co"l, d~,~iUI 1.
While the present invention has been illustrated and described with particularity in terms of a preferred e,l,bodi,ll~llL. it should be understood that no limitation of the scope of the invention is intended thereby. The scope of the invention is defined only by the claims appended hereto. It should also be understood that variations of the particular embodiment WO 95115785 PCTIIJS9~/1.112.1 described herein i"uo",ordLi"g the principles of the present invention will occur to those of ordinary skill in the art and yet be within the scope of the appended claims. It should further be d~ uidI~d that while the method of the present invention has been disclosed as being i",~ ler,L~d with a Illil.lU~JlUCe:ssoll it is also possible to i,l~l le",e"l the method utilizing aColll~illdLiol1 of analog circuits and hardwired digital logic.
For automatic and dynamic adjustment of the stimulation energy level to be successful, it is necessary for the i",,ulal,~dble cardiac stimulator to be able to verify that capture has occurred. Capture verification is generally dcco",,u'i~lled by detecting an electrical potential in the heart evoked by the 10 stimulating pulse. If capture has not occurred, there will be no evoked potential to detect. It follows that each time a stimulating pulse is delivered to the heart, the heart can be monitored during an dpplU,~Iid~t: period of time thereafter to detect the presence of the evoked potential, and thereby verify capture. In practice, however, reliable detection of the evoked 15 potential is not a simple matter, especially where it is desired to sense theevoked potential with the same electrode that delivers the stimulating pulse.
This is because the evoked potential is small in amplitude relative to the residual pOIdl i~dliol1 charge on the electrode resulting from the stimulation pulse. The residual charge decays exponentially but tends to dominate the 20 evoked potential for several hundreds of ", " - 1.1~ thereafter. Several techniques for alleviating the effects of the residual charge are disclosed in the prior art.
U.S. Patent No. 4,858,610, issued August 22, 1989, to Callaghan et al., teaches the use of charge dumping following delivery of the stimulating 25 pulse to decrease lead poldli~dLiull and also the use of separate pacing and sensing electrodes to eliminate the poldli~d~iull problem on the sensing electrode. U.S. Patent No. 4,686,988, issued August 18,1987, to Sholder, teaches the use of a separate sensing electrode connected to a detector for detecting P-waves in the presence of atrial stimulation pulses, wherein the 30 P-wave detector has an input bandpass ~ dld~ Li~, selected to pass frequencies that are ~so~ t~d with P-waves. U.S. Patent No. 4,373,531 teaches the use of pre- and post-stimulation recharge pulses to neutralize WO 9S11578~ ` 2 1 7 8 4 8 5 PCT/US9.1/1 112-1 the polarization on the lead. U.S. Patent No. 4,537,201 teaches a linearization of the ~xpo~ 'ly decaying sensed signal by applying the sensed signal through an anti-loyd,iIi""ic amplifier in order to detect a remaining nonlinear component caused by the evoked potential. U.S.
Patent No. 4,674,509, issued June 23, 1987, to DeCote, Jr. teaches the gel1e~liol1 of paired pacing pulses spaced such that at most only one pulse of each pair can induce capture. The waveforms sensed through the pacing lead following the gel1eld~iol) of each of the pair of pulses are ~let;l,~,lli,.~'!y subtracted to yield a difference signal indicative of the evoked cardiac response.
It would be desirable to provide a signal p, ~ ssi"g method for use in an implantable cardiac stimulator that permits detection of cardiac evoked potentials in the presence of a residual charge from a preceding stimulation pulse in order to verify capture of the heart, and that permits use of the same electrode to sense the evoked response as was used to deliver the stimulation pulse. This and other desirable goals are met by the present invention .
Disclosure of the Invention I have invented a method for di~ llilld~illg between capture and non-capture signal mo~ IJholo~i~s that are sensed following delivery of the output pulse of a pact:l"dh~,. Observing that the non-capture potential is xpol~l ILidl in form and the evoked capture potential, while generally exponential in form, has one or more small-amplitude perturbations superimposed on the expol1t:"Ii~l waveform, the invention seeks to enhance these perturbations for ease of detection. The perturbations involve relatively abrupt slope changes, which are enhanced by processing the waveform signal by dir~ ,lLidliol1 to render the second derivative of the evoked response. Abrupt slope changes in the second derivative are used to detect morphological features indicative of capture which are otherwise often difficult to di:~,lilllilldL~. In order to eliminate detection of abrupt slope wo 95/15785 2 ~ 7 8 ~ 8 5 PCT/US9~ 12~ ~
changes caused by noise the preferred embodiment employs a lowpass filter prior to l r~1~111idliul~.
In aucurddllc~ with one aspect of the invention a method of verifying cardiac capture involves sensing via an electrode a cardiac signal evoked in response to a cardiac stimulation pulse. The sensed signal is hltered to remove noise. The hltered signal is processed to render a waveform signal ~pr~ser,1il,g the second derivative of the hltered signal. If minimum and maximum amplitude excursions of the second derivative signal occur within a selected window of time following delivery of the cardiac stimulation pulse and if the amplitude difference between the minimum and maximum exceeds a reference value then capture is determined to have occurred.
It is an object of the present invention to provide an improved method fomiibl lilllilldLillg non-capture and capture waveform morphologies as sensed by an intracardiac electrode following delivery of a cardiac stimulating pulse.
It is a further object of the present invention to provide an improved method for d;b~ lilld~illg capture waveform mu,~ oloyi~s from intrinsic col,1,duliun waveform Illor~.huluyit:s as sensed by an ill11dcdldidc electrode following delivery of a cardiac stimulating pulse.
Other objects and advantages of the present invention will be apparent from the following des,~ Jliull of a preferred tllllbodi",~"~ made with reference to the drawings.
Brief Desc.;,~,1ion of the Drawings FIG. 1 is a block diagram of the preferred embodiment of a cardiac stimulator i"co,~uordLi"g the present invention.
FIG. 2 is a block diagram of the capture sense block of FIG. 1 showing in greater particularity a capture sense analog signal plucebbi"g circuit.
FIGS. 3 4 and 5 illustrate a series of waveforms showing relevant properties of first and second derivatives of sensed waveforms.
WO95115785 ; 2 1 78485 PCI'/ITS9111~112 FIGS. 6 and 7 illustrate a series of waveforms showing the usefulness of the second derivative in discriminating between capture and non-capture sensed waveforms.
FIG. 8 illustrates a second derivative of a sensed waveform relative 5 to certain time windows and amplitude thresholds that are useful in connection with the method of the present invention.
FIG. 9 is a flow chart of the method of analyzing the second derivative of a sensed waveform to detect capture of the heart in accordance with the present invention.
Best Mode for Carrying out the Invention Referring in particular to FIG. 1, there is illustrated a block diagram of a uaut~ ah~r 10 incorporating the method of the present invention. A
luplucesaor and control circuit 20 preferably provides pacemaker control and means for pruce~illy digital signals. Mi~,lu~luc~ ol 20 has 5 inpuVoutput ports connected in a conventional manner via bi-directional bus 22 to memory 24. Memory 24 preferably includes both ROM and RAM.
The pact,n,dh~r operating routine is stored in ROM. The RAM stores various plUyldlllllldble pdldlll~ > and variables.
Microprocessor 20 preferably also has an inpuVoutput port connected 20 to a telemetry interface 26 by line 28. The pacemaker when implanted is thus able to receive pacing control pdldlllllL~ and variables from a L~d~1sl,lilL~r of an external p,oy,d"",lel and send data to a receiver of the external ~IUyldllllll~l if desired. Telemetry communication is preferably effected by ~Idl~Sl"iaSiul~ and reception, via antenna 30, of eleu~lu",ay,letic 25 radiation modulated in accordance with the data to be communicated.
Microprocessor 20 also has output ports cu~ eu~d to inputs of an atrial stimulus pulse generator 32 and a ventricular stimulus pulse generator 34 by control lines 36 and 38, respectively. Microprocessor 20 sends pulse parameter data, such as amplitude and width, as well as enable/disable and 30 pulse initiation codes to the generators 32 and 34 on the respective control lines 36 and 38.
WO 95/15785 ~ 7 8 ~ 8 5 PCT/U59.111~12 Microprocessor 20 also has input ports connected to outputs of an atrial sense amplifier 40 and a ventricular sense amplifier 42 by lines 44 and 46 respectively. The atrial and ventricular sense amplihers 40 and 42 detect occurrences of P-waves and R-waves respectively. The atrial sense amplifier 40 puts out a signal on line 44 to microprocessor 20 when a P-wave is detected. The ventricular sense amplifier 42 puts out a signal on line 46 to ~iu~upruc~ssol 20 when an R-wave is detected.
The input of the atrial sense amplifier 40 and the output of the atrial stimulus pulse generator 32 are connected to a first conductor 48 which is connected via a conventional atrial lead to a pacing/sensing electrode 50 preferably lodged within the right atrial chamber of the heart 52.
The input of the ventricular sense amplifier 42 and the output of the ventricular stimulus pulse generator 34 are connected to a second conductor 54 which is connected via a conventional ventricular lead to a pacing/sensing electrode 56 preferably lodged within the right ventricular chamber of the heart 52.
The conductors 48 and 54 conduct the stimulus pulses generated by the atrial and ventricular stimulus pulse y~ dlUI~ 32 and 34 respectively to the pacing/sensing electrodes 50 and 56. The pacing/sensing electrodes 50 and 56 and collu~pul~di,ly conductors 48 and 54 also conduct sensed cardiac electrical signals in the right atrium and right ventricle to the atrialand ventricular sense amplifiers 40 and 42 respectively.
A capture sense signal processor 58 has an input connected to conductor 54 and an output connected via line 60 to an input port of ~iu~up~ucessor 20. A signal sensed in the ventricle by electrode 56 is conducted via conductor 54 to capture sense signal processor 58 where the sensed signal is processed in a manner described further below. The processed signal from capture sense signal processor 58 is conducted via line 60 to microprocessor 20 where the signal undergoes further processing and analysis in acculdallc~ with a method described below.
The present invention contemplates detecting capture of the heart by sensing via an electrode placed in the heart an electrical potential evoked in .`, ~ 2 1 7 8 4 8 5 WO 9511578~ PCT/US9~11~1111 response to ~ ' I of a stimulating pulse A signihcant advantage of the present invention is that the same electrode that is used to deliver the stimulating pulse can also be used for detecting capture. This allows use of unipolar pacing between the lead tip and the pacer can without requiring a 5 separate ring electrode for capture detection. Alternatively, bipolar pacing between the lead tip and ring electrode can be used without requiring a third electrode. In addition, when using bipolar pacing the tip electrode can be used as the capture detection electrode. Another advantage is that non-capture can be detected within 7U ms affer delivery of the pacing pulse, 10 which is early enough to permit a backup pacing pulse to be delivered i"l",edidl~ly, if desired.
Referring to FIG. 2, the capture sense signal processor 58 of FIG. 1 is illustrated in greater detail. In the preferred embodiment, signal processor 58 includes a pre-amplifier 62 having an input to which sensed 15 electrical activity signals from the heart are applied. The input of pre-amplifier 62 is t~ lly connected via conductor 54 of an endocardial lead to the tip electrode 56 located in the right ventricle of the heart. The signal from tip electrode 56 is sensed relative to a second electrode, preferably an external conductive surface of the pa~ dh~l housing or 20 "can," in a unipolar pacing configuration. Nevertheless, it should be u~delbl~ d that the input to pre-amplifier 62 can also be ~;olllle~ d to a ring electrode Alternatively, the input to pre-amplifier 62 can be connected to the tip electrode 56 with the signal being sensed relative to a ring electrode in a bipolar pacing configuration Finally, it should be appreciated 25 that capture sense signal processor 58, while shown ~,u~ e~ d to an electrode within a ventricle, could be connected instead to an electrode within an atrium of the heart The amplified output signal of pre-amplifier 62 is applied to the input of a following lowpass filter stage 64 having a cutoff frequency of about 50 30 Hz. Lowpass filter stage 64 is employed to remove high frequency noise that is not indicative of capture but that might cause false detection of capture ~ ~f~ 21 78485 WO 95/15785 PCT/US9`1/1~112-1 The hltered output of filter stage 64 is applied to the input of a following analog to digital converter stage 66 in which the amplified and hltered analog signal is digitized for further prucessil,g by microprocessor 20 in accordance with the capture detection method described below.
FIGS~ 3, 4 and 5 illustrate some general properties of the derivatives of evoked response morphologies. More particularly, FIGS. 3(a), 4(a) and 5(a) show hypothetical evoked response morphologies FIGS. 3(b), 4(b) and 5(b) show the first derivatives of the morphologies of FIGS. 3(a), 4(a) and 5(a), respectively. FIGS. 3(c), 4(c) and 5(c) show the second derivatives of the Illoll,holoyit:s of FIGS. 3(a), 4(a) and 5(a), respectively.
An exponential, or nearly exponential, waveform 68 has a first derivative 70 and a second derivative 72 that are smooth and exponential, or nearly exponential. Exponential waveforms 74 and 76, with perturbations, have first derivatives 78 and 80, respectively, which e~dgg~ldL~ the perturbations.
The first derivative waveforms may or may not cross zero as illustrated by waveforms 78 and 80, respectively. Second derivative waveforms 82 and 84 further emphasize the perturbations and cross zero as the slope of the first derivative reaches an inflection point.
FIGS. 6 and 7 illustrate the power of the method of the present invention for di~l,lilllilldlillg an evoked response waveform indicative of capture from a non-capture waveform. FIGS. 6(a) and 7(a) show sensed waveforms representative of non-capture and capture events, respectively.
FIGS. 6(b) and 7(b) show the sensed waveforms after being lowpass filtered to remove noise. FIGS. 6(c) and 7(c) show the second derivatives of the filtered wavefomms.
A four volt, 1 millisecond wide unipolar pulse was delivered to the heart between a tip electrode of a lead and the pacemaker case. The resultant waveform was sensed between the tip and case. The task is to di:~l;lilllilld~:l the non-capture morphology 86 from the capture morphology 88. Waveforms 86 and 88 correspond to typical input waveforms to the capture sense signal processor 58 of Fig. 1. The output waveforms 90, 92 of lowpass filter 64 as shown in FIGS. 6(b) and 7(b) are difficult to WO 951157~ PCTrUS9.1~1.112 t r~
diau~ illd~ The second derivatives 94, 96 generated in a~col~dl,c~ with the method of the present invention clearly develop the perturbations in the capture Illor~ oloyy, whereas the non-capture morphology remains relatively featureless.
Referring to FIGS. 8 and 9, the method of the present invention is illustrated It should be understood that the filtered and digitized signal from capture sense signal processor 58 is analyzed by Illiulu,uruc~ssor 20 in accordance with the procedure illustrated in FIG. 9, including the prior step of I ' 'r~ Lidli~g the digitized sensed waveform to render the second 1û derivative. FIG. 8 shows a portion of the second derivative waveform having a varying amplitue A as viewed within a first window of time from about 40 msec to about 70 msec after delivery of the stimulating pulse. If both a minimum peak A1 and a maximum peak A2 are not found by the end of the 40 to 70 msec window of time, the stimulating pulse is classified as not having captured the heart, provided that the absolute value of the amplitude A has not exceeded the absolute value of an ~Ill,ui~ l!y determined threshold value Ref2, such as .00005 V/sec2, or -Ref2, such as -.00005 V/sec2, within that hrst window of time. If at least one minimum peak A1 and one maximum peak A2 (which may occur in either order) are found within the 40 to 70 msec window, but the peak-to-peak amplitude difference between A1 and A2 is less than an e",pi,iu~y determined threshold value Refl, such as .00001 V/sec2 for instance, the stimulating pulse is also classified as not having captured the heart, provided that the absolute value of the amplitude has not exceeded the absolute value of threshold value Ref2. If the peak-to-peak amplitude difference between A1 and A2 is equal to or greater than the threshold value Ref1, it is tentatively determined that capture has occurred, although it is possible that the peak-to-peak excursion has exceeded the first threshold value Ref, not due to an evoked response indicative of capture~ but due to the occurrence of an intrinsic co,lllc:,,[ioll "lallir~ d within the first window of time. Signals generated by intrinsic conllduliulls tend to be of siylliriua"lly greater magnitude than evoked l~pullses indicative of capture. The method ` 2178485 WO 95/15785 PCT/US9 1/l ll~
measures the amplitude A of the second derivative over an extended window of time, i.e., from about 40 ms to about 100 ms after deiivery of the stimulating pulse, to identify intrinsic contractions. If the absolute value of the amplitude A exceeds the absolute value of the second threshold value 5 Ref2 within the extended window of time, it is d~L~""il~ed that an intrinsic Cu"l,d-,lion has occurred. If the absolute value of the amplitude A does not exceed the absolute value of the second threshold Ref2 at any time during the extended window of time from about 40 ms to about 100 ms, and if the peak-to-peak amplitude difference has exceeded the first threshold Ref, 10 during the first window of time from about 40 ms to about 70 ms, it is d~ "i"ed that capture has occurred.
Referring in particular to FIG. 9, the method of the present invention is described in greater detail with respect to the analysis of the second derivative of the sensed waveform performed by microprocessor 20, with 15 the second derivative also being rendered by ~iu~up~uct:ssor 20. Starting at a selected delay of about 40 ms after delivery of the stimulating pulse, the method compares the absolute value of the waveform amplitude A to the absolute value of a reference value Ref2, as indicated by decision box 100. If the absolute value of the amplitude A exceeds the absolute value of 20 Ref2, it is determined that an intrinsic contraction has occurred, as indicated by box 102. If the absolute value of the amplitude A does not exceed the absolute value of Ref2, the Culllpdli~ul~ is repeated until either the absolute value of the amplitude A exceeds Ref2 or time t=70 ms is reached, as indicated by decision box 104. Alternatively, positive and negative 25 amplitude peaks A2 and A, can be compared to UUllt:::.UUI~dill9 positive and negative reference values Ref2 and -Ref2 rather than UUIII~Jdlillg the absolute value of the amplitude A to the absolute value of Ref2.
At time t=70, if the waveform has not previously been classified as an intrinsic contraction, the method determines whether an amplitude 30 maximum and minimum have been found during the interval from t=40 to t=70, as indicated by decision box 106. If both maximum and minimum peaks have not been found, it is detemmined that capture has not occurred, - : : 21 784~5 WO 95/1578~; PCT/US9~/1412~
as indicated by box 108. if both maximum and minimum amplitude peaks have been found the method determines whether the absolute value of the amplitude difference between the maximum and minimum amplitude peaks is less than a reference value Ref" as indicated by decision box 110. If the 5 amplitude difference is less than Ref" then it is d~L~ ,i"ed that capture has not occurred as indicated by box 108. If the amplitude difference is equal to or exceeds Ref" the method determines whether the absolute value of the waveform amplitude A exceeds the absolute value of Ref2 as indicated by decision box 112. If the absolue value of Ref2 is exceeded it is 10 cl~L~r"~i"ed that the waveform is the result of an intrinsic ~ d~.liUII rather than a capture as indicated by box 114. If the absolute value of the waveform amplitude A is equal to or less than the absolute value of Ref2 then the method continues to compare the absolute value of the amplitude to the absolue value of Ref2 until either the absolue value of Ref2 is exceeded or t=100 ms as indicated by decision box 116. If t=100 ms without the absolute value of Ref2 having been exceeded during the period t=70 to P100 then it is determined that a capture occurred as indicated by box 118.
In the event that c.rl 1 ~ Jn of the method described above and illustrated in FIG. 9 results in a determination of non-capture as of the end of the first window of time at t=70 as indicated by box 108 it may nevertheless be useful to continue to look for intrinsic contractions that are Illall '~ - within that portion of the extended window of time from t=70 to t=100 ms. This can be acc~",~ ed by cu"" a~i"g the absolute value of the waveform amplitude A to the absolute value of Ref2 from t=70 to t=100.
If the absolute value of Ref2 is exceeded during that time period it will be determined that a non-capture was followed by an intrinsic co"l, d~,~iUI 1.
While the present invention has been illustrated and described with particularity in terms of a preferred e,l,bodi,ll~llL. it should be understood that no limitation of the scope of the invention is intended thereby. The scope of the invention is defined only by the claims appended hereto. It should also be understood that variations of the particular embodiment WO 95115785 PCTIIJS9~/1.112.1 described herein i"uo",ordLi"g the principles of the present invention will occur to those of ordinary skill in the art and yet be within the scope of the appended claims. It should further be d~ uidI~d that while the method of the present invention has been disclosed as being i",~ ler,L~d with a Illil.lU~JlUCe:ssoll it is also possible to i,l~l le",e"l the method utilizing aColll~illdLiol1 of analog circuits and hardwired digital logic.
Claims
-13-11. A method of detecting cardiac capture by sensing via an electrode (56) a cardiac signal after delivery of a cardiac stimulation pulse, comprising the steps of:
sensing a waveform signal at said electrode following delivery of said cardiac stimulation pulse; and filtering (64) said sensed waveform signal to pass frequencies characteristic of an evoked cardiac capture signal;
characterized by:
a) processing said filtered waveform signal to render a second derivative waveform signal representin the second derivative of said filtered signal;
b) processing and analyzing (106) said second derivative waveform signal to detect a minimum (A1) and a maximum (A2)amplitude excursion during a selected window of time beginning at a selected time delay following delivery of said cardiac stimulation pulse;
c) measuring the amplitude difference (¦A2 - A?¦) between said minimum and said maximum;
d) comparing said amplitude difference to a reference vaiue (Ref1);
and e) performing one of the following:
1) generating a non-capture detect signal (108) if said amplitude difference does not exceed said reference value;
2) generating a capture detect signal (118) if said amplitude difference exceeds said reference value.
12. The method of Claim 11, and further including the steps of:
f) measuring the amplitude (¦A¦) of said second derivative wavefcrm signal during a second selected window of time beginning at a selected time delay following delivery of said cardiac stimulation pulse;
g) comparing (112) said amplitude to a second reference value (Ref2); and h) generating an intrinsic contraction detect signal (114) if, and only if, said amplitude exceeds said second reference value during said second selected window of time.
13. The method of Claim 12, in which said second window of time ends at a time later than said first window of time.
14. The method of Claim 12, in which step e) is performed if, and only if, an intrinsic contraction detect signal is not generated pursuant to step h).
15. The method of Claim 12, in which said second reference value is greater than said first reference value.
16. The method of Claim 13 or 14, in which said second reference value is greater than said first reference value.
17. The method of Claim 13 or 15, in which step e) is performed if, and only if, an intrinsic contraction detect signal is not generated pursuant to step h).
18. The method of claim 14 or 15, in which said second window of time ends at a time later than said first window of time.
sensing a waveform signal at said electrode following delivery of said cardiac stimulation pulse; and filtering (64) said sensed waveform signal to pass frequencies characteristic of an evoked cardiac capture signal;
characterized by:
a) processing said filtered waveform signal to render a second derivative waveform signal representin the second derivative of said filtered signal;
b) processing and analyzing (106) said second derivative waveform signal to detect a minimum (A1) and a maximum (A2)amplitude excursion during a selected window of time beginning at a selected time delay following delivery of said cardiac stimulation pulse;
c) measuring the amplitude difference (¦A2 - A?¦) between said minimum and said maximum;
d) comparing said amplitude difference to a reference vaiue (Ref1);
and e) performing one of the following:
1) generating a non-capture detect signal (108) if said amplitude difference does not exceed said reference value;
2) generating a capture detect signal (118) if said amplitude difference exceeds said reference value.
12. The method of Claim 11, and further including the steps of:
f) measuring the amplitude (¦A¦) of said second derivative wavefcrm signal during a second selected window of time beginning at a selected time delay following delivery of said cardiac stimulation pulse;
g) comparing (112) said amplitude to a second reference value (Ref2); and h) generating an intrinsic contraction detect signal (114) if, and only if, said amplitude exceeds said second reference value during said second selected window of time.
13. The method of Claim 12, in which said second window of time ends at a time later than said first window of time.
14. The method of Claim 12, in which step e) is performed if, and only if, an intrinsic contraction detect signal is not generated pursuant to step h).
15. The method of Claim 12, in which said second reference value is greater than said first reference value.
16. The method of Claim 13 or 14, in which said second reference value is greater than said first reference value.
17. The method of Claim 13 or 15, in which step e) is performed if, and only if, an intrinsic contraction detect signal is not generated pursuant to step h).
18. The method of claim 14 or 15, in which said second window of time ends at a time later than said first window of time.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/165,251 US5431693A (en) | 1993-12-10 | 1993-12-10 | Method of verifying capture of the heart by a pacemaker |
US08/165,251 | 1993-12-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2178485A1 true CA2178485A1 (en) | 1995-06-15 |
Family
ID=22598106
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002178485A Abandoned CA2178485A1 (en) | 1993-12-10 | 1994-12-08 | Method of verifying capture of the heart by a pacemaker |
Country Status (7)
Country | Link |
---|---|
US (1) | US5431693A (en) |
EP (1) | EP0732961B1 (en) |
JP (1) | JPH09508819A (en) |
CA (1) | CA2178485A1 (en) |
DE (1) | DE69404672T2 (en) |
ES (1) | ES2105882T3 (en) |
WO (1) | WO1995015785A1 (en) |
Families Citing this family (152)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5607457A (en) * | 1995-09-29 | 1997-03-04 | Schueller; Hans | Pacemaker with evoked response detection by using differential sensing between two unipolar electrodes |
US5571144A (en) * | 1995-12-18 | 1996-11-05 | Intermedics, Inc. | Method of verifying capture of the atrium by a cardiac stimulator |
US8825152B2 (en) | 1996-01-08 | 2014-09-02 | Impulse Dynamics, N.V. | Modulation of intracellular calcium concentration using non-excitatory electrical signals applied to the tissue |
JP4175662B2 (en) * | 1996-01-08 | 2008-11-05 | インパルス ダイナミクス エヌ.ヴイ. | Electric muscle control device |
US9289618B1 (en) | 1996-01-08 | 2016-03-22 | Impulse Dynamics Nv | Electrical muscle controller |
US8321013B2 (en) | 1996-01-08 | 2012-11-27 | Impulse Dynamics, N.V. | Electrical muscle controller and pacing with hemodynamic enhancement |
US7167748B2 (en) * | 1996-01-08 | 2007-01-23 | Impulse Dynamics Nv | Electrical muscle controller |
US9713723B2 (en) | 1996-01-11 | 2017-07-25 | Impulse Dynamics Nv | Signal delivery through the right ventricular septum |
US5697957A (en) * | 1996-08-29 | 1997-12-16 | Pacesetter Ab | Adaptive method and apparatus for extracting an evoked response component from a sensed cardiac signal by suppressing electrode polarization components |
SE9604215D0 (en) | 1996-11-18 | 1996-11-18 | Pacesetter Ab | Tissue stimulation apparatus |
EP0857493B1 (en) * | 1997-02-10 | 2004-11-10 | St. Jude Medical AB | Heart stimulating device with variable stimulation energy |
US5772691A (en) * | 1997-04-14 | 1998-06-30 | Sulzer Intermedics Inc. | Implantable cardiac stimulator with polarity detection for detecting ectopic beats |
US5800466A (en) * | 1997-04-14 | 1998-09-01 | Sulzer Intermedics Inc. | Dynamic atrial detection sensitivity control in an implantable medical cardiac simulator |
US5843133A (en) * | 1997-04-14 | 1998-12-01 | Sulzer Intermedics Inc. | Dynamic bandwidth control in an implantable medical cardiac stimulator |
US5735881A (en) * | 1997-04-14 | 1998-04-07 | Sulzer Intermedics Inc. | Variable atrail blanking period in an implantable medical device |
US5873898A (en) | 1997-04-29 | 1999-02-23 | Medtronic, Inc. | Microprocessor capture detection circuit and method |
US5861013A (en) * | 1997-04-29 | 1999-01-19 | Medtronic Inc. | Peak tracking capture detection circuit and method |
SE9703600D0 (en) * | 1997-10-02 | 1997-10-02 | Pacesetter Ab | Heart stimulator |
US6128535A (en) * | 1997-12-05 | 2000-10-03 | Cardiac Pacemakers, Inc. | Automatic capture verification in multisite cardiac pacing |
US6152954A (en) | 1998-07-22 | 2000-11-28 | Cardiac Pacemakers, Inc. | Single pass lead having retractable, actively attached electrode for pacing and sensing |
SE9800407D0 (en) * | 1998-02-12 | 1998-02-12 | Pacesetter Ab | Heart stimulator |
US5954756A (en) * | 1998-04-09 | 1999-09-21 | Medtronic, Inc. | Microprocessor capture detection circuit and method |
SE9802150D0 (en) | 1998-06-16 | 1998-06-16 | Pacesetter Ab | Heart stimulator |
SE9802151D0 (en) | 1998-06-16 | 1998-06-16 | Pacesetter Ab | Heart stimulator |
SE9802152D0 (en) | 1998-06-16 | 1998-06-16 | Pacesetter Ab | Heart stimulator |
US6463334B1 (en) | 1998-11-02 | 2002-10-08 | Cardiac Pacemakers, Inc. | Extendable and retractable lead |
US6501990B1 (en) | 1999-12-23 | 2002-12-31 | Cardiac Pacemakers, Inc. | Extendable and retractable lead having a snap-fit terminal connector |
JP3281867B2 (en) * | 1998-08-05 | 2002-05-13 | 三菱重工業株式会社 | Signal processing device |
US6163724A (en) * | 1998-09-18 | 2000-12-19 | Medtronic, Inc. | Microprocessor capture detection circuit and method |
US6324427B1 (en) * | 1999-01-26 | 2001-11-27 | Pacesetter, Inc. | Implantable cardiac stimulation device having T-wave discrimination of fusion events during autocapture/autothreshold assessment |
US8666495B2 (en) | 1999-03-05 | 2014-03-04 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US8700161B2 (en) | 1999-03-05 | 2014-04-15 | Metacure Limited | Blood glucose level control |
US8019421B2 (en) | 1999-03-05 | 2011-09-13 | Metacure Limited | Blood glucose level control |
US9101765B2 (en) | 1999-03-05 | 2015-08-11 | Metacure Limited | Non-immediate effects of therapy |
US6179865B1 (en) * | 1999-04-01 | 2001-01-30 | Cardiac Pacemakers, Inc. | Cross chamber interval correlation |
US7203535B1 (en) | 1999-04-01 | 2007-04-10 | Cardiac Pacemakers, Inc. | System and method for classifying tachycardia arrhythmias having 1:1 atrial-to-ventricular rhythms |
US6473649B1 (en) | 1999-12-22 | 2002-10-29 | Cardiac Pacemakers, Inc. | Rate management during automatic capture verification |
US6615089B1 (en) | 2000-03-31 | 2003-09-02 | Cardiac Pacemakers, Inc. | System and method for verifying capture in a multi-site pacemaker |
US6522914B1 (en) * | 2000-07-14 | 2003-02-18 | Cardiac Pacemakers, Inc. | Method and apparatuses for monitoring hemodynamic activities using an intracardiac impedance-derived parameter |
US6684100B1 (en) * | 2000-10-31 | 2004-01-27 | Cardiac Pacemakers, Inc. | Curvature based method for selecting features from an electrophysiologic signals for purpose of complex identification and classification |
US7069070B2 (en) * | 2003-05-12 | 2006-06-27 | Cardiac Pacemakers, Inc. | Statistical method for assessing autonomic balance |
US6567701B2 (en) | 2000-12-21 | 2003-05-20 | Medtronic, Inc. | Method and system for discriminating captured beats from non-captured beats in a cardiac pacing system |
DE10129649A1 (en) * | 2001-06-14 | 2002-12-19 | Biotronik Mess & Therapieg | stimulation device |
US6697673B1 (en) | 2001-09-13 | 2004-02-24 | Pacesetter, Inc. | Implantable stimulation device and method for detecting capture of a heart chamber using cross-chamber conducted depolarization |
US6772008B2 (en) | 2001-09-28 | 2004-08-03 | Cardiac Pacemakers, Inc. | Method and apparatus for avoidance of phrenic nerve stimulation during cardiac pacing |
US6687545B1 (en) | 2001-10-23 | 2004-02-03 | Pacesetter, Inc. | Cardiac stimulation system and method for performing automatic capture verification during bipolar stimulation |
US6937901B2 (en) * | 2001-10-31 | 2005-08-30 | Cardiac Pacemakers, Inc. | Capture verification for cardiac resynchronization pacing optimization |
US7392085B2 (en) * | 2001-11-21 | 2008-06-24 | Cameron Health, Inc. | Multiple electrode vectors for implantable cardiac treatment devices |
US7248921B2 (en) | 2003-06-02 | 2007-07-24 | Cameron Health, Inc. | Method and devices for performing cardiac waveform appraisal |
US7330757B2 (en) | 2001-11-21 | 2008-02-12 | Cameron Health, Inc. | Method for discriminating between ventricular and supraventricular arrhythmias |
US6885893B1 (en) | 2002-03-25 | 2005-04-26 | Pacesetter, Inc. | Implantable stimulation device and method for performing inter-chamber conduction search and conduction time measurement |
US7738959B2 (en) * | 2002-09-30 | 2010-06-15 | Medtronic, Inc. | Method and apparatus for performing stimulation threshold searches |
US7203543B2 (en) * | 2002-10-23 | 2007-04-10 | Cardiac Pacemakers, Inc. | Method and system for detecting capture using a coronary vein electrode |
DE10250996A1 (en) * | 2002-10-30 | 2004-05-13 | Biotronik Meß- und Therapiegeräte GmbH & Co. Ingenieurbüro Berlin | Stimulation device with stimulation success control |
US7101339B2 (en) | 2002-12-13 | 2006-09-05 | Cardiac Pacemakers, Inc. | Respiration signal measurement apparatus, systems, and methods |
US8050764B2 (en) | 2003-10-29 | 2011-11-01 | Cardiac Pacemakers, Inc. | Cross-checking of transthoracic impedance and acceleration signals |
US7272442B2 (en) | 2002-12-30 | 2007-09-18 | Cardiac Pacemakers, Inc. | Automatically configurable minute ventilation sensor |
US7191004B2 (en) * | 2002-12-31 | 2007-03-13 | Cardiac Pacemakers, Inc. | Capture verification using an evoked response reference |
US7162301B2 (en) * | 2002-12-31 | 2007-01-09 | Cardiac Pacemakers, Inc. | Method and system for detecting capture with cancellation of pacing artifact |
US7349738B1 (en) * | 2003-02-19 | 2008-03-25 | Pacesetter, Inc. | Detecting atrial evoked response |
WO2004080533A1 (en) | 2003-03-10 | 2004-09-23 | Impulse Dynamics Nv | Apparatus and method for delivering electrical signals to modify gene expression in cardiac tissue |
US11439815B2 (en) | 2003-03-10 | 2022-09-13 | Impulse Dynamics Nv | Protein activity modification |
US20040215276A1 (en) * | 2003-04-25 | 2004-10-28 | Patrick Scholten | Form analysis to detect evoked response |
US7477932B2 (en) | 2003-05-28 | 2009-01-13 | Cardiac Pacemakers, Inc. | Cardiac waveform template creation, maintenance and use |
US7500955B2 (en) * | 2003-06-27 | 2009-03-10 | Cardiac Pacemaker, Inc. | Signal compression based on curvature parameters |
US7792571B2 (en) | 2003-06-27 | 2010-09-07 | Cardiac Pacemakers, Inc. | Tachyarrhythmia detection and discrimination based on curvature parameters |
US7200440B2 (en) | 2003-07-02 | 2007-04-03 | Cardiac Pacemakers, Inc. | Cardiac cycle synchronized sampling of impedance signal |
US8792985B2 (en) | 2003-07-21 | 2014-07-29 | Metacure Limited | Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar |
US7392084B2 (en) * | 2003-09-23 | 2008-06-24 | Cardiac Pacemakers, Inc. | Demand-based cardiac function therapy |
US20060247693A1 (en) | 2005-04-28 | 2006-11-02 | Yanting Dong | Non-captured intrinsic discrimination in cardiac pacing response classification |
US7319900B2 (en) * | 2003-12-11 | 2008-01-15 | Cardiac Pacemakers, Inc. | Cardiac response classification using multiple classification windows |
US7774064B2 (en) | 2003-12-12 | 2010-08-10 | Cardiac Pacemakers, Inc. | Cardiac response classification using retriggerable classification windows |
US8521284B2 (en) * | 2003-12-12 | 2013-08-27 | Cardiac Pacemakers, Inc. | Cardiac response classification using multisite sensing and pacing |
US8352031B2 (en) | 2004-03-10 | 2013-01-08 | Impulse Dynamics Nv | Protein activity modification |
US11779768B2 (en) | 2004-03-10 | 2023-10-10 | Impulse Dynamics Nv | Protein activity modification |
US8548583B2 (en) | 2004-03-10 | 2013-10-01 | Impulse Dynamics Nv | Protein activity modification |
KR100601953B1 (en) * | 2004-05-03 | 2006-07-14 | 삼성전자주식회사 | Capacitor of memory device and fabrication method thereof |
US7515956B2 (en) * | 2004-05-12 | 2009-04-07 | Cardiac Pacemakers, Inc. | Template based AV/VA interval comparison for the discrimination of cardiac arrhythmias |
US7627366B1 (en) * | 2004-05-17 | 2009-12-01 | Pacesetter, Inc. | Analysis of polarization information |
US7706866B2 (en) | 2004-06-24 | 2010-04-27 | Cardiac Pacemakers, Inc. | Automatic orientation determination for ECG measurements using multiple electrodes |
US7509170B2 (en) | 2005-05-09 | 2009-03-24 | Cardiac Pacemakers, Inc. | Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes |
US7805185B2 (en) | 2005-05-09 | 2010-09-28 | Cardiac Pacemakers, In. | Posture monitoring using cardiac activation sequences |
US7890159B2 (en) | 2004-09-30 | 2011-02-15 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring and tracking |
US7917196B2 (en) | 2005-05-09 | 2011-03-29 | Cardiac Pacemakers, Inc. | Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes |
US7797036B2 (en) | 2004-11-30 | 2010-09-14 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring for ischemia detection |
US7647108B2 (en) * | 2004-09-30 | 2010-01-12 | Cardiac Pacemakers, Inc. | Methods and systems for selection of cardiac pacing electrode configurations |
US7457664B2 (en) | 2005-05-09 | 2008-11-25 | Cardiac Pacemakers, Inc. | Closed loop cardiac resynchronization therapy using cardiac activation sequence information |
US7376458B2 (en) * | 2004-11-29 | 2008-05-20 | Cameron Health, Inc. | Method for defining signal templates in implantable cardiac devices |
US7477935B2 (en) * | 2004-11-29 | 2009-01-13 | Cameron Health, Inc. | Method and apparatus for beat alignment and comparison |
EP1827571B1 (en) | 2004-12-09 | 2016-09-07 | Impulse Dynamics NV | Protein activity modification |
US7761162B2 (en) * | 2004-12-13 | 2010-07-20 | Cardiac Pacemakers, Inc. | Capture verification with intrinsic response discrimination |
US8160697B2 (en) | 2005-01-25 | 2012-04-17 | Cameron Health, Inc. | Method for adapting charge initiation for an implantable cardioverter-defibrillator |
WO2006097934A2 (en) | 2005-03-18 | 2006-09-21 | Metacure Limited | Pancreas lead |
US7392086B2 (en) | 2005-04-26 | 2008-06-24 | Cardiac Pacemakers, Inc. | Implantable cardiac device and method for reduced phrenic nerve stimulation |
US7574260B2 (en) | 2005-04-28 | 2009-08-11 | Cardiac Pacemakers, Inc. | Adaptive windowing for cardiac waveform discrimination |
US7765004B2 (en) | 2005-04-28 | 2010-07-27 | Cardiac Pacemakers, Inc. | Methods and systems for managing fusion and noise in cardiac pacing response classification |
US7337000B2 (en) | 2005-04-28 | 2008-02-26 | Cardiac Pacemakers Inc. | Selection of cardiac signal features detected in multiple classification intervals for cardiac pacing response classification |
US7499751B2 (en) * | 2005-04-28 | 2009-03-03 | Cardiac Pacemakers, Inc. | Cardiac signal template generation using waveform clustering |
US7392088B2 (en) * | 2005-04-28 | 2008-06-24 | Cardiac Pacemakers, Inc. | Capture detection for multi-chamber pacing |
FR2888511A1 (en) * | 2005-07-12 | 2007-01-19 | Ela Medical Soc Par Actions Si | ACTIVE IMPLANTABLE CARDIAC PROSTHESIS MEDICAL DEVICE COMPRISING IMPROVED MEANS OF DISCRIMINATION BETWEEN EFFICIENT AND INADEQUATE EFFICIENT STIMULATIONS |
US7529578B2 (en) * | 2005-07-12 | 2009-05-05 | Cardiac Pacemakers, Inc. | Multi channel approach to capture verification |
US8116867B2 (en) | 2005-08-04 | 2012-02-14 | Cameron Health, Inc. | Methods and devices for tachyarrhythmia sensing and high-pass filter bypass |
US7693574B2 (en) | 2005-08-31 | 2010-04-06 | Cardiac Pacemakers, Inc. | System and method for discriminating high frequency electromagnetic interference from cardiac events |
US7783340B2 (en) * | 2007-01-16 | 2010-08-24 | Cameron Health, Inc. | Systems and methods for sensing vector selection in an implantable medical device using a polynomial approach |
US8200341B2 (en) | 2007-02-07 | 2012-06-12 | Cameron Health, Inc. | Sensing vector selection in a cardiac stimulus device with postural assessment |
US8788023B2 (en) | 2006-05-26 | 2014-07-22 | Cameron Health, Inc. | Systems and methods for sensing vector selection in an implantable medical device |
US7623909B2 (en) | 2006-05-26 | 2009-11-24 | Cameron Health, Inc. | Implantable medical devices and programmers adapted for sensing vector selection |
US8527048B2 (en) | 2006-06-29 | 2013-09-03 | Cardiac Pacemakers, Inc. | Local and non-local sensing for cardiac pacing |
US7580741B2 (en) * | 2006-08-18 | 2009-08-25 | Cardiac Pacemakers, Inc. | Method and device for determination of arrhythmia rate zone thresholds using a probability function |
US8209013B2 (en) | 2006-09-14 | 2012-06-26 | Cardiac Pacemakers, Inc. | Therapeutic electrical stimulation that avoids undesirable activation |
US8948867B2 (en) * | 2006-09-14 | 2015-02-03 | Cardiac Pacemakers, Inc. | Capture detection with cross chamber backup pacing |
US8712507B2 (en) * | 2006-09-14 | 2014-04-29 | Cardiac Pacemakers, Inc. | Systems and methods for arranging and labeling cardiac episodes |
US7941208B2 (en) | 2006-11-29 | 2011-05-10 | Cardiac Pacemakers, Inc. | Therapy delivery for identified tachyarrhythmia episode types |
US8265736B2 (en) | 2007-08-07 | 2012-09-11 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
US9037239B2 (en) | 2007-08-07 | 2015-05-19 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
US20090054947A1 (en) * | 2007-08-20 | 2009-02-26 | Medtronic, Inc. | Electrode configurations for directional leads |
US8295943B2 (en) | 2007-08-20 | 2012-10-23 | Medtronic, Inc. | Implantable medical lead with biased electrode |
WO2009025817A2 (en) | 2007-08-20 | 2009-02-26 | Medtronic, Inc. | Evaluating therapeutic stimulation electrode configurations based on physiological responses |
EP2254661B1 (en) | 2008-02-14 | 2015-10-07 | Cardiac Pacemakers, Inc. | Apparatus for phrenic stimulation detection |
US8050751B2 (en) * | 2008-07-31 | 2011-11-01 | Medtronic, Inc. | Periodic beat detection to detect artifacts in a cardiac electrogram |
EP2349467B1 (en) | 2008-10-06 | 2017-08-23 | Cardiac Pacemakers, Inc. | Dynamic cardiac resynchronization therapy by tracking intrinsic conduction |
JP5684239B2 (en) * | 2009-05-04 | 2015-03-11 | インセプト・リミテッド・ライアビリティ・カンパニーIncept Llc | Biomaterial for track and puncture closure |
US8934975B2 (en) | 2010-02-01 | 2015-01-13 | Metacure Limited | Gastrointestinal electrical therapy |
US9872990B2 (en) | 2011-05-13 | 2018-01-23 | Saluda Medical Pty Limited | Method and apparatus for application of a neural stimulus |
CN103648583B (en) | 2011-05-13 | 2016-01-20 | 萨鲁达医疗有限公司 | For measuring method and the instrument of nerves reaction-A |
WO2012155184A1 (en) | 2011-05-13 | 2012-11-22 | National Ict Australia Ltd | Method and apparatus for measurement of neural response - c |
US9974455B2 (en) | 2011-05-13 | 2018-05-22 | Saluda Medical Pty Ltd. | Method and apparatus for estimating neural recruitment |
WO2012155185A1 (en) | 2011-05-13 | 2012-11-22 | National Ict Australia Ltd | Method and apparatus for measurement of neural response |
AU2013344311B2 (en) | 2012-11-06 | 2017-11-30 | Saluda Medical Pty Ltd | Method and system for controlling electrical conditions of tissue |
EP2967404B1 (en) | 2013-03-11 | 2019-05-22 | Cameron Health, Inc. | Device implementing dual criteria for arrhythmia detection |
US9579065B2 (en) | 2013-03-12 | 2017-02-28 | Cameron Health Inc. | Cardiac signal vector selection with monophasic and biphasic shape consideration |
US9604065B2 (en) | 2013-08-30 | 2017-03-28 | Cardiac Pacemakers, Inc. | Unwanted stimulation detection during cardiac pacing |
US9533159B2 (en) | 2013-08-30 | 2017-01-03 | Cardiac Pacemakers, Inc. | Unwanted stimulation detection during cardiac pacing |
US11172864B2 (en) | 2013-11-15 | 2021-11-16 | Closed Loop Medical Pty Ltd | Monitoring brain neural potentials |
EP3071100B1 (en) | 2013-11-22 | 2024-01-03 | Saluda Medical Pty Limited | Method and device for detecting a neural response in a neural measurement |
CN106456984B (en) | 2014-02-24 | 2019-07-09 | 元素科学公司 | External defibrillator |
US10368762B2 (en) | 2014-05-05 | 2019-08-06 | Saluda Medical Pty Ltd. | Neural measurement |
ES2873255T3 (en) | 2014-07-25 | 2021-11-03 | Saluda Medical Pty Ltd | Neurological stimulation dosage |
AU2015349614B2 (en) | 2014-11-17 | 2020-10-22 | Saluda Medical Pty Ltd | Method and device for detecting a neural response in neural measurements |
WO2016090420A1 (en) | 2014-12-11 | 2016-06-16 | Saluda Medical Pty Ltd | Implantable electrode positioning |
EP3218046B1 (en) | 2014-12-11 | 2024-04-17 | Saluda Medical Pty Ltd | Device and computer program for feedback control of neural stimulation |
WO2016115596A1 (en) | 2015-01-19 | 2016-07-28 | Saluda Medical Pty Ltd | Method and device for neural implant communication |
EP3957356A1 (en) | 2015-04-09 | 2022-02-23 | Saluda Medical Pty Limited | Electrode to nerve distance estimation |
AU2016273415B2 (en) | 2015-05-31 | 2021-07-15 | Closed Loop Medical Pty Ltd | Monitoring brain neural activity |
EP3302692A4 (en) | 2015-05-31 | 2019-01-16 | Saluda Medical Pty Limited | Brain neurostimulator electrode fitting |
CN107613861B (en) | 2015-06-01 | 2021-10-26 | 闭环医疗私人有限公司 | Motor fiber neuromodulation |
US9610045B2 (en) * | 2015-07-31 | 2017-04-04 | Medtronic, Inc. | Detection of valid signals versus artifacts in a multichannel mapping system |
CN108289611B (en) | 2015-08-26 | 2021-08-06 | 元素科学公司 | Wearable device |
US11191966B2 (en) | 2016-04-05 | 2021-12-07 | Saluda Medical Pty Ltd | Feedback control of neuromodulation |
JP7278076B2 (en) | 2016-06-24 | 2023-05-19 | サルーダ・メディカル・ピーティーワイ・リミテッド | Nerve stimulation to reduce artifacts |
US11944820B2 (en) | 2018-04-27 | 2024-04-02 | Saluda Medical Pty Ltd | Neurostimulation of mixed nerves |
US11253715B2 (en) | 2018-10-10 | 2022-02-22 | Element Science, Inc. | Wearable medical device with disposable and reusable components |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4114627A (en) * | 1976-12-14 | 1978-09-19 | American Hospital Supply Corporation | Cardiac pacer system and method with capture verification signal |
US4373531A (en) * | 1979-04-16 | 1983-02-15 | Vitafin N.V. | Apparatus for physiological stimulation and detection of evoked response |
US4290430A (en) * | 1980-06-05 | 1981-09-22 | Intermedics, Inc. | Pacer analyzer |
US4649931A (en) * | 1981-03-02 | 1987-03-17 | Medtronic, Inc. | Sampled data sense amplifier |
FR2533432A1 (en) * | 1982-09-23 | 1984-03-30 | Europ Propulsion | METHOD AND DEVICE FOR DETECTING THE HEART RESPONSE TO AN ELECTRIC STIMULUS PULSE |
US4543956A (en) * | 1984-05-24 | 1985-10-01 | Cordis Corporation | Biphasic cardiac pacer |
US4686988A (en) * | 1984-10-19 | 1987-08-18 | Sholder Jason A | Pacemaker system and method for measuring and monitoring cardiac activity and for determining and maintaining capture |
US4674509A (en) * | 1985-05-28 | 1987-06-23 | Cordis Corporation | System and method for detecting evoked cardiac contractions |
US4674508A (en) * | 1985-05-28 | 1987-06-23 | Cordis Corporation | Low-power consumption cardiac pacer based on automatic verification of evoked contractions |
US4895152A (en) * | 1985-12-11 | 1990-01-23 | Telectronics N.V. | System for cardiac pacing |
US4766901A (en) * | 1985-12-18 | 1988-08-30 | Telectronics N.V. | Rate responsive pacing system using the integrated evoked potential |
US4759367A (en) * | 1986-03-19 | 1988-07-26 | Telectronics N.V | Rate responsive pacing using the magnitude of the repolarization gradient of the ventricular gradient |
US4759366A (en) * | 1986-03-19 | 1988-07-26 | Telectronics N.V. | Rate responsive pacing using the ventricular gradient |
US4827934A (en) * | 1987-10-27 | 1989-05-09 | Siemens-Pacesetter, Inc. | Sensing margin detectors for implantable electromedical devices |
US4878497A (en) * | 1988-03-25 | 1989-11-07 | Telectronics N.V. | Pacemaker with improved automatic output regulation |
DE3816042A1 (en) * | 1988-05-10 | 1989-11-23 | Alt Eckhard | ENERGY SAVING HEART PACEMAKER |
EP0392048A1 (en) * | 1989-04-12 | 1990-10-17 | Siemens-Elema AB | Medical implantable apparatus to stimulate a physiological function of a living being with an adjustable stimulative intensity, and method to adjust the stimulation intensity |
US5033473A (en) * | 1989-10-24 | 1991-07-23 | Hewlett-Packard Company | Method for discriminating pace pulse tails |
US5018523A (en) * | 1990-04-23 | 1991-05-28 | Cardiac Pacemakers, Inc. | Apparatus for common mode stimulation with bipolar sensing |
EP0464252B1 (en) * | 1990-07-06 | 1994-10-19 | Pacesetter AB | Device for tissue stimulation |
US5265603A (en) * | 1990-12-12 | 1993-11-30 | Medtronic, Inc. | Electronic capture detection for a pacer |
US5127401A (en) * | 1990-11-09 | 1992-07-07 | Medtronic, Inc. | Method of and apparatus for multi-vector pacing artifact detection |
US5184615A (en) * | 1991-03-08 | 1993-02-09 | Telectronics Pacing Systems, Inc. | Apparatus and method for detecting abnormal cardiac rhythms using evoked potential measurements in an arrhythmia control system |
-
1993
- 1993-12-10 US US08/165,251 patent/US5431693A/en not_active Expired - Lifetime
-
1994
- 1994-12-08 ES ES95904293T patent/ES2105882T3/en not_active Expired - Lifetime
- 1994-12-08 EP EP95904293A patent/EP0732961B1/en not_active Expired - Lifetime
- 1994-12-08 CA CA002178485A patent/CA2178485A1/en not_active Abandoned
- 1994-12-08 JP JP7516345A patent/JPH09508819A/en active Pending
- 1994-12-08 WO PCT/US1994/014124 patent/WO1995015785A1/en active IP Right Grant
- 1994-12-08 DE DE69404672T patent/DE69404672T2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1995015785A1 (en) | 1995-06-15 |
EP0732961B1 (en) | 1997-07-30 |
JPH09508819A (en) | 1997-09-09 |
DE69404672D1 (en) | 1997-09-04 |
EP0732961A1 (en) | 1996-09-25 |
ES2105882T3 (en) | 1997-10-16 |
DE69404672T2 (en) | 1998-02-26 |
US5431693A (en) | 1995-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2178485A1 (en) | Method of verifying capture of the heart by a pacemaker | |
US5571144A (en) | Method of verifying capture of the atrium by a cardiac stimulator | |
US8792971B2 (en) | Method and apparatus for identifying oversensing using far-field intracardiac electrograms and marker channels | |
EP0717646B1 (en) | Apparatus and method for capture detection in a cardiac stimulator | |
EP1615693B1 (en) | Apparatus for identifying cardiac and non-cardiac oversensing using intracardiac electrograms | |
US6427085B1 (en) | Cardiac sense amplifier for capture verification | |
US5861013A (en) | Peak tracking capture detection circuit and method | |
EP1427473B1 (en) | Multiple templates for filtering of far field r-waves | |
US8078277B2 (en) | Identification and remediation of oversensed cardiac events using far-field electrograms | |
US9474456B2 (en) | Active medical device, including an implantable defibrillator, for detection of QRS complexes in a very noisy signal | |
US20020143370A1 (en) | Method and device for sensing atrial depolarizations during ventricular tachycardia | |
EP0778050A2 (en) | Implantable medical device having cardiac event detection system | |
US6954671B1 (en) | Implantable heart stimulator or which identifies the origin of heart signals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |